Home
>
National Drug Code (NDC)
>
Labetalol
Labetalol - 25021-300-20 - (Labetalol Hydrochloride)
Drug Information of Labetalol
| Product NDC: | 25021-300 |
| Proprietary Name: | Labetalol |
| Non Proprietary Name: | Labetalol Hydrochloride |
| Active Ingredient(s): | 5 mg/mL & nbsp; Labetalol Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Labetalol
| Product NDC: | 25021-300 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079134 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100217 |
Package Information of Labetalol
| Package NDC: | 25021-300-20 |
| Package Description: | 1 VIAL in 1 CARTON (25021-300-20) > 20 mL in 1 VIAL |
NDC Information of Labetalol
| NDC Code | 25021-300-20 |
| Proprietary Name | Labetalol |
| Package Description | 1 VIAL in 1 CARTON (25021-300-20) > 20 mL in 1 VIAL |
| Product NDC | 25021-300 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Labetalol Hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100217 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | LABETALOL HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
